Jefferies Starts Tourmaline Bio (TRML) at Buy
Tweet
Share
E-mailGet Alerts TRML Hot Sheet
Price: $47.98 --0%
Rating Summary:
1 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
1 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Jefferies analyst Roger Song initiates coverage on Tourmaline Bio (NASDAQ: TRML) with a Buy rating and a price target of $41.00.
For an analyst ratings summary and ratings history on Tourmaline Bio click here. For more ratings news on Tourmaline Bio click here.
Shares of Tourmaline Bio closed at $19.10 yesterday.
You May Also Be Interested In
- BofA Securities Starts Kanzhun Ltd. (BZ) at Neutral
- Goldman Sachs Starts Luxshare Precision (2475:HK) at Buy
- Craig-Hallum Starts Horizon Quantum (HQ) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
